Topical non-steroidal drugs are systemically absorbed and may cause renal disease.
Andrews
P A
PA
SW Thames Renal Unit, St Helier Hospital, Surrey, UK.
Sampson
S A
SA
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001539:Bendroflumethiazide / Q000009:adverse effects*; D001706:Biopsy; D004232:Diuretics / Q000009:adverse effects* / Q000627:therapeutic use; D005279:Fenoprofen / Q000009:adverse effects*; D005920:Glomerular Mesangium / Q000473:pathology; D005923:Glomerulosclerosis, Focal Segmental / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D010003:Osteoarthritis / Q000188:drug therapy / Q000503:physiopathology*; D010146:Pain; D013997:Time Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004232:Diuretics; D001539:Bendroflumethiazide; D005279:Fenoprofen